Traditional Chinese medicine composition for treating hemorrhagic eye diseases and preparation method of traditional Chinese medicine composition

A hemorrhagic and compositional technology, which is applied in drug combinations, blood diseases, pharmaceutical formulations, etc., can solve problems such as difficult operation, high hygiene requirements, adverse reactions and complications
CN112336833AInactive Publication Date: 2021-02-09周燕英
3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN Β· China
Current Assignee / Owner
周燕英
Publication Date
2021-02-09
Estimated Expiration
Not applicable Β· inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a traditional Chinese medicine composition for treating hemorrhagic eye diseases and a preparation method of the traditional Chinese medicine composition, relates to the technical field of traditional Chinese medicines, and aims at solving the problems that the hemorrhagic eye diseases including macular degeneration, retinal vein occlusion and the like have retinal blood circulation disturbance of different degrees, tissue blood supply is insufficient, abnormal blood vessels are generated, and lesions are caused. The traditional Chinese medicine composition is mainly used for improving eyesight, activating blood circulation to dissipate stasis, promoting and improving retinal blood circulation, dredging blood vessels, increasing blood supply, improving ischemia andanoxia conditions of tissues and promoting absorption of bleeding, edema, exudation and fibroproliferative organized tissues, so as to achieve a treatment effect.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to the technical field of traditional Chinese medicine, more specifically, it relates to a traditional Chinese medicine composition for treating hemorrhagic eye disease and a preparation method thereof. Background technique

[0002] Causes of hemorrhagic eye diseases include macular degeneration, retinal vein occlusion, and diabetic retinopathy. In February 2004, the anti-vascular endothelial growth factor drugs approved by the US Food and Drug Administration (referred to as anti-VE and F drugs) became the first-line drugs for colon or rectal metastatic cancer. In 2006, anti-VE and F drugs were approved for use. He has made a breakthrough in the treatment of hemorrhagic eye diseases in the Department of Ophthalmology and won the American New Medicine Award.

[0003] However, there are the following defects in the anti-VE and F class drugs used in ophthalmology for the treatment of hemorrhagic eye diseases:

[0004] 1. The scope ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More